Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Gothenburg, Sweden. 31 March 2026. Mölnlycke®, a global leader in MedTech, today welcomes the publication of Shaping the future of wound care in Europe, the first joint industry white paper from the MedTech Europe Wound Care Sector Working Group. The wound paper highlights the growing burden of chronic wounds and urges EU policymakers to elevate wound care as a strategic health priority across the EU.

Across Europe, up to 14.9 million people suffer from chronic wounds, placing a significant and often overlooked burden on patients, caregivers and health systems1,2,3. Chronic wound care consumes up to 4% of European healthcare budgets, driven by delayed diagnosis, prolonged treatment, preventable complications and workforce strain2.
Despite this scale, chronic wounds remain under-recognised in policy and are often treated as secondary concerns, even though conditions such as diabetic foot ulcers carry a five-year mortality rate comparable to certain cancers4. The white paper underscores that no wound begins as chronic, but becomes chronic when prevention, early intervention and coordinated care fall short.
To address these challenges, the white paper identifies three priority areas for reform:
Building on these priorities, the white paper outlines four recommendations for coordinated action among policymakers, clinicians, payers, patient organisations, and industry:
Mölnlycke strongly supports these recommendations, emphasising the need to overcome fragmentation of care, strengthen clinician education and invest in prevention to reduce chronicity.
“Chronic wounds are preventable, yet patients continue to suffer because care is fragmented and intervention comes too late. By prioritising prevention, strengthening clinician training and building integrated pathways, Europe can dramatically improve outcomes and reduce avoidable burden on patients and healthcare systems,” says Isabella Notarangelo, Governmental Affairs and Policy Manager at Mölnlycke as well as Co-Vice Chair of the MedTech Europe Wound Care Sector Working Group. Isabella added “This white paper provides a clear roadmap, now it’s time for policymakers to act.”
As Europe moves toward outcome-focused care models, Mölnlycke believes value-based healthcare is the most sustainable path to prevention, earlier diagnosis, fewer complications, more efficient care and better patient outcomes.
Read the full white paper: Shaping the future of wound care in Europe https://www.medtecheurope.org/resource-library/shaping-the-future-of-wound-care-in-europe/
For more information, please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.
Tue, Mar 24, 2026 Today, it was announced that Zlatko Rihter, CEO of Mölnlycke Health Care, has informed the Board of Directors of his decision to resign. Following his decision, Guillaume Joucla, Chief Financial Officer, has been appointed interim CEO of Mölnlycke Health Care. Mölnlycke’s Board has initiated the recruitment process for a permanent CEO.
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
Gothenburg, Sweden. 21 August 2025. Mölnlycke®, a world-leading MedTech company, has once again been recognised as a global sustainability leader, earning the prestigious EcoVadis Platinum medal for the second year in a row.
A new peer-reviewed study published in the Journal of Hospital Infection underscores the critical role of double gloving and indicator systems in reducing the risk of undetected glove breaches during surgery.
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
Gothenburg, Sweden. 21 May 2025 – Mölnlycke Health Care, a global leader in MedTech, has officially opened its new global headquarters at GoCo Health Innovation City in Gothenburg, Sweden—a major milestone in its journey to drive sustainable healthcare innovation.